Journey Medical Corp (DERM) returns
Journey Medical returns over 3 years
$1,000 invested in Journey Medical three years ago was worth $1,616 at the close on October 30, 2026, with dividends reinvested: an average return of 17.3% a year. The same $1,000 in the S&P 500 (SPY) became $1,885.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -24.4% | — | $755.85 | -0.9% |
| 3 months | -19.8% | — | $801.55 | +2.1% |
| Year to date | -32.9% | — | $670.56 | +11.7% |
| 1 year | -37.8% | — | $622.14 | +12.4% |
| 3 years | +61.6% | +17.3% | $1,616 | +88.5% |
Journey Medical return by calendar year
| Year | DERM | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -32.9% | +11.7% | -44.6% |
| 2025 | +97.2% | +17.7% | +79.5% |
| 2024 | -32.1% | +24.9% | -57.0% |
| 2023 | +200.0% | +26.2% | +173.8% |
| 2022 | -64.3% | -18.2% | -46.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: DERM financials
No forecast, no recommendation. This page describes Journey Medical Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.